Supplements

Colloidal silver: particles, promises and actual medical uses

8 sources · Latest source check 2026-10-17 UTC

On this page

Colloidal silver is a liquid containing tiny silver particles. It is sometimes marketed online as a dietary supplement. Silver is not an essential nutrient, and swallowing it has no established nutritional function. A supplement claim should therefore be assessed separately from the material’s chemical description.[1]

Colloidal, ionic and hydrosol mean different things

A colloid contains dispersed particles; ionic silver is silver present as electrically charged ions. A silver hydrosol uses water as the liquid medium and can contain both metal particles and ions. These categories can overlap within one bottle. EFSA describes particles releasing dissolved ions as their surfaces change in water.[2]

A 2020 laboratory investigation examined 14 silver products from 10 brands, including liquids, sprays and gels. Their particles, concentrations and production batches varied considerably. The study measured product composition, rather than whether taking a product improved health. Its results do not establish the composition of every bottle sold today.[3]

A prescription burn cream is a different exposure

Silver sulfadiazine is a specific topical medicine. The SILVADENE label lists use alongside other care to prevent or treat wound infection in second- and third-degree burns. It is a prescription cream for skin use, with contraindications and warnings. That indication does not authorize drinking a silver supplement or treating an ordinary illness with one.[4]

Killing microbes in a dish is a starting point

Researchers can investigate antimicrobial effects without establishing that a consumer treatment works. In a small 2017 crossover trial, 22 people with persistent chronic sinus disease enrolled and 20 completed treatment with silver and saline nasal sprays. Silver did not meaningfully improve symptom or endoscopic scores. This tests a nasal product in a defined condition, not swallowed silver against every infection.[5]

A reassuring short study has limits

An oral-exposure study enrolled 60 healthy volunteers and tested commercial silver solutions over periods of up to 14 days. It found no clinically important changes in the measured blood, urine, examination or imaging outcomes. That result deserves reporting. It did not test disease prevention, years of use, pregnancy, or all other formulations; it cannot establish a universal long-term ingestion threshold.[6]

The researchers excluded volunteers with significant acute or chronic disease, including specified renal impairment. Their tests assessed particular organ and laboratory measurements rather than every possible effect. A null finding in that design is useful evidence about those measurements during that exposure, while leaving cumulative effects and more vulnerable populations unresolved.[6]

A supplement label does not settle a treatment claim

US regulation 21 CFR 310.548 addresses silver ingredients offered as over-the-counter drugs to prevent or treat disease. It states that adequate data do not establish general recognition of safety and effectiveness for those uses; an approved drug application is required. This is a specific drug framework, not a statement that every silver-containing medical product has identical uses or risks.[7]

FDA’s January 2023 warning letter to one seller illustrates why wording matters: disease claims established drug intent, and FDA described the marketed product as an unapproved new drug. This is a dated enforcement example, not a current survey of all brands. Check what the seller actually promises, including linked articles cited on the selling website.[8]

What a test report can and cannot establish

A concentration or particle-size report answers a composition question. In the 2020 product study, measured silver frequently differed from label claims, and some batches differed from each other. Ask whether a report identifies the exact product, batch and analytical method. Accurate composition still would not demonstrate improved immunity or justify replacing a prescribed treatment.[3]

Evidence & uncertainty

Chemistry matters, but a more technical product name is not evidence of benefit. EFSA found the submitted evidence insufficient to assess the safety or absorption of one silver-hydrosol supplement source; that was an identified evidence gap, not proof of an effective nutritional ingredient.[2]

Selected-source overview · Independent review pending

Published questions

Is silver hydrosol a proven safer alternative to colloidal silver?

Selected-source overview · Independent review pending. Read the evidence context.

The name alone cannot establish that. Hydrosol can contain both particles and dissolved ions. EFSA could not assess the submitted source’s safety or absorption from the available evidence. A name or composition claim does not establish disease-treatment effectiveness.[2][7]

Evidence behind this answer

Safety and bioavailability of silver hydrosol as a source of silver added for nutritional purposes to food supplements
agency scientific assessment · 2018
Full text selected definitions, dossier assessment and conclusions inspected · Abstract, Summary, sections 3.1.1, 3.3–3.4 and conclusions; dossier-specific assessment
21 CFR 310.548: Drug products containing colloidal silver ingredients or silver salts offered OTC for disease treatment or prevention
regulation · 1999
Original page text, selected relevant sections inspected · Paragraphs (a)–(d); current display up to date 15 October 2026; originating final rule August 1999